Citations

Clear

7732 citation(s) found for "Ma, Daniel".

CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
Brenchley, Jason M. , Schacker, Timothy W. , Ruff, Laura E., Price, David A. , Taylor, Jodie H., Beilman, Gregory J. , Nguyen, Phuong L., Khoruts, Alexander , Larson, Matthew , Haase, Ashley T. , Douek, Daniel C.

Mayo Clinic

The Journal of Experimental Medicine | September 13, 2004 | Volume: 200 | Issue: 6 | Pages: 749-759

10.1084/jem.20040874 | PMID 15365096 Get It

The mechanisms underlying CD4+ T cell depletion in human immunodeficiency virus (HIV) infection are not well understood. Comparative studies of lymphoid tissues, where the vast majority of T cells reside, and peripheral blood can potentially illuminate the pathogenesis of HIV-associated disease. Here, we studied the effect of HIV infection on the activation and depletion of defined subsets of CD4+ and CD8+ T cells in the blood, gastrointestinal (GI) tract, and lymph node (LN). We also measured HIV-specific T cell frequencies in LNs and blood, and LN collagen deposition to define architectural changes associated with chronic inflammation. The major findings to emerge are the following: the GI tract has the most substantial CD4+ T cell depletion at all stages of HIV disease; this depletion occurs preferentially within CCR5+ CD4+ T cells; HIV-associated immune activation results in abnormal accumulation of effector-type T cells within LNs; HIV-specific T cells in LNs do not account for all effector T cells; and T cell activation in LNs is associated with abnormal collagen deposition. Taken together, these findings define the nature and extent of CD4+ T cell depletion in lymphoid tissue and point to mechanisms of profound depletion of specific T cell subsets related to elimination of CCR5+ CD4+ T cell targets and disruption of T cell homeostasis that accompanies chronic immune activation.
Dual Secretagogue Drive of Burst-Like Growth Hormone Secretion in Postmenopausal Compared with Premenopausal Women Studied under an Experimental Estradiol Clamp
Erickson, Dana , Keenan, Daniel M., Mielke, Kristi L., Bradford, Kandace, Bowers, Cyril Y., Miles, John M., Veldhuis, Johannes D. , Miles, John M.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | September 7, 2004 | Volume: 89 | Issue: 9 | Pages: 4746-4754

10.1210/jc.2004-0424 | PMID 15356089 Get It

Normative Sexual Behavior in Children: A Contemporary Sample
Friedrich, William N., Fisher, Jennifer, Broughton, Daniel D., Houston, Margaret S., Shafran, Constance R.

Mayo Clinic

Pediatrics | August 13, 2004 | Volume: 101 | Issue: 4 | Pages: e9-e9

10.1542/peds.101.4.e9 | PMID 9521975 Get It

Objective. Sexual behavior in children can cause uncertainty in the clinician because of the relationship between sexual abuse and sexual behavior. Consequently, it is important to understand normative childhood sexual behavior. Design. Sexual behavior in 1114 2- to 12-year-old children was rated by primary female caregivers. These children were screened for the absence of sexual abuse. A 38-item scale assessing a broad range of sexual behavior (Child Sexual Behavior Inventory, Third Version) was administered along with the Child Behavior Checklist and a questionnaire assessing family stress, family sexuality, social maturity of the child, maternal attitudes regarding child sexuality, and hours in day care. Results. Sexual behavior was related to the child's age, maternal education, family sexuality, family stress, family violence, and hours/week in day care. Frequencies of sexual behaviors for 2- to 5-, 6- to 9-, and 10- to 12-year-old boys and girls are presented. Conclusions. A broad range of sexual behaviors are exhibited by children who there is no reason to believe have been sexually abused. Their relative frequency is similar to two earlier studies, and this reinforces the validity of these results.
Linkage Disequilibrium Testing When Linkage Phase Is Unknown
Schaid, Daniel J.

Mayo Clinic

Genetics | August 2, 2004 | Volume: 166 | Issue: 1 | Pages: 505-512

10.1534/genetics.166.1.505 | PMID 15020439 Get It

Abstract Linkage disequilibrium, the nonrandom association of alleles from different loci, can provide valuable information on the structure of haplotypes in the human genome and is often the basis for evaluating the association of genomic variation with human traits among unrelated subjects. But, linkage phase of genetic markers measured on unrelated subjects is typically unknown, and so measurement of linkage disequilibrium, and testing whether it differs significantly from the null value of zero, requires statistical methods that can account for the ambiguity of unobserved haplotypes. A common method to test whether linkage disequilibrium differs significantly from zero is the likelihood-ratio statistic, which assumes Hardy-Weinberg equilibrium of the marker phenotype proportions. We show, by simulations, that this approach can be grossly biased, with either extremely conservative or liberal type I error rates. In contrast, we use simulations to show that a composite statistic, proposed by Weir and Cockerham, maintains the correct type I error rates, and, when comparisons are appropriate, has similar power as the likelihood-ratio statistic. We extend the composite statistic to allow for more than two alleles per locus, providing a global composite statistic, which is a strong competitor to the usual likelihood-ratio statistic.
Hemangioblastoma of the Optic Nerve
Kerr, Daniel J., Scheithauer, Bernd W., Miller, Gary M. , Ebersold, Michael J., McPhee, Thomas J.

Mayo Clinic

Neurosurgery | July 30, 2004 | Volume: 36 | Issue: 3 | Pages: 573-581

10.1097/00006123-199503000-00017 Get It

Management of Intracranial Infectious Aneurysms: A Series of 16 Cases
Phuong, Loi K., Link, Michael J. , Barrow, Daniel L. , Wijdicks, Eelco F. M. , Barrow, Daniel L

Mayo Clinic

Neurosurgery | July 30, 2004 | Volume: 51 | Issue: 5 | Pages: 1145-1152

10.1097/00006123-200211000-00008 | PMID 12383359 Get It

Abstract OBJECTIVE The purpose of this study was to better define the management of intracranial infectious aneurysms. METHODS We present a retrospective review of the management of 16 patients with intracranial infectious aneurysms. The mean follow-up period was 86 months. RESULTS None of the patients had a rehemorrhage during antibiotic treatment. The mortality and long-term outcome from ruptured intracranial infectious aneurysms may be better than previously thought. There was no significant difference in long-term outcome between patients with single or multiple infectious aneurysms or between patients who underwent surgical resection and those who were treated only with antibiotics. CONCLUSION Operative treatment should be pursued for patients with ruptured infectious aneurysms. Patients with unruptured intracranial infectious aneurysms should be observed during antibiotic therapy and followed up with cerebral angiography. Surgical resection should be considered if the aneurysm enlarges and the patient's general medical condition allows general anesthesia to be tolerated.
Forehead Flap Periorbital Reconstruction
Price, Daniel L. , Sherris, David A., Bartley, George B., Garrity, James A., Price, Daniel L

Mayo Clinic

Archives of Facial Plastic Surgery | July 19, 2004 | Volume: 6 | Issue: 4 | Pages: 222-227

10.1001/archfaci.6.4.222 | PMID 15262715 Get It

Phase III Study of Adjuvant Chemotherapy and Radiation Therapy Compared With Chemotherapy Alone in the Surgical Adjuvant Treatment of Colon Cancer: Results of Intergroup Protocol 0130
Martenson, James A., Willett, Christopher G. , Sargent, Daniel J. , Mailliard, James A., Donohue, John H., Gunderson, Leonard L., Thomas, Charles R., Fisher, Barbara, Benson, Al B. , Myerson, Robert J., Goldberg, Richard M. , Sargent, Daniel J

Mayo Clinic

Journal of Clinical Oncology | July 13, 2004 | Volume: 22 | Issue: 16 | Pages: 3277-3283

10.1200/jco.2004.01.029 | PMID 15249584 Get It

Purpose Some patients with colon cancer have a high risk of local recurrence postoperatively. This trial was undertaken to determine whether radiation therapy added to an adjuvant chemotherapy regimen improves outcome in high-risk patients. Patients and Methods Patients with resected colon cancer with tumor adherence or invasion of surrounding structures, or with T3N1 or T3N2 tumors of the ascending or descending colon were randomly assigned to receive fluorouracil and levamisole therapy with or without radiation therapy. Patients who received chemotherapy and radiation therapy (chemoRT) received 45 to 50.4 Gy in 25 to 28 fractions beginning 28 days after starting chemotherapy. Patient enrollment was terminated because of slow accrual after 222 patients enrolled (original goal was 700 patients); 187 patients were assessable. Results Overall 5-year survival was 62% for chemotherapy patients and 58% for chemoRT patients (P > .50); 5-year disease-free survival was 51% for both groups (P > .50). Toxicity (≥ grade 3) occurred in 42% of chemotherapy patients and 54% of chemoRT patients (P = .04). Leukopenia (≥ grade 3) occurred in 10% of chemotherapy patients and 22% of chemoRT patients (P = .02). No significant difference in nonhematologic toxicity (≥ grade 3) was observed between chemoRT and chemotherapy patients (35% v 44%; P = .26). Conclusion Patients who received chemotherapy or chemoRT had similar overall survival and disease-free survival. Toxicity was higher among chemoRT patients. These results must be interpreted with caution because of the high number of ineligible patients and the limited power of the study to detect potentially meaningful differences.
Combination of Isoflurane and Caspase Inhibition Reduces Cerebral Injury in Rats Subjected to Focal Cerebral Ischemia
Inoue, Satoki , Drummond, John C., Davis, Daniel P. , Cole, Daniel J. , Patel, Piyush M.

Mayo Clinic

Anesthesiology | June 22, 2004 | Volume: 101 | Issue: 1 | Pages: 75-81

10.1097/00000542-200407000-00013 | PMID 15220774 Get It

Background Recent data indicate that the neuroprotective efficacy of isoflurane is not sustained. Delayed neuronal death, mediated in part by apoptosis, contributes to the gradual increase in the size of the infarction. These data suggest that isoflurane may not be able to inhibit delayed neuronal death. The prevention of apoptosis by a caspase inhibitor might provide neuroprotection in addition to that provided by isoflurane. The current study was conducted to determine whether isoflurane-mediated neuroprotection can be made more durable with the administration of z-VAD-fmk, a nonspecific caspase inhibitor. Methods Fasted Wister rats were allocated to awake-zVAD, awake-vehicle, isoflurane-zVAD, or isoflurane-vehicle groups (n = 16/group). Animals were subjected to focal ischemia for 60 min by filament occlusion of the middle cerebral artery. In the awake groups, isoflurane was discontinued after occlusion of the middle cerebral artery. In the isoflurane groups, isoflurane anesthesia was maintained at 1.5 minimum alveolar concentration during occlusion of the middle cerebral artery. Before and after ischemia, daily injections of z-VAD-fmk or vehicle were administered into the lateral cerebral ventricle for 14 days. Neurologic assessment was performed 14 days after ischemia. The volume of cerebral infarction and the number of intact neurons in the periinfarct cortex were determined by image analysis of hematoxylin and eosin-stained coronal brain sections. Results Infarction volume was less in the isoflurane-zVAD group (23 +/- 11 mm, mean +/- SD) than in isoflurane-vehicle, awake-vehicle, and awake-zVAD groups (82 +/- 31, 86 +/- 31, and 59 +/- 25 mm, respectively; P < 0.05). In comparison with the awake-vehicle and isoflurane-vehicle groups, the administration of z-VAD-fmk significantly decreased infarction volume (P < 0.05). The infarction volume between the awake-vehicle and isoflurane-vehicle groups was not different. The number of intact neurons within the periinfarct cortex was significantly less in the awake-vehicle group than in the other three groups (P < 0.05). The isoflurane-zVAD group demonstrated better neurologic function than the awake-vehicle group (P < 0.05). Conclusion These findings are consistent with the premise that ongoing delayed neuronal death, in part mediated by apoptosis, contributes to the progression of cerebral infarction during the recovery period, and its inhibition can provide sustained neuroprotection.
Substitution of Oral Fluoropyrimidines for Infusional Fluorouracil With Radiotherapy: How Much Data Do We Need?
Crane, Christopher H. , Sargent, Daniel J. , Sargent, Daniel J

Mayo Clinic

Journal of Clinical Oncology | June 22, 2004 | Volume: 22 | Issue: 15 | Pages: 2978-2981

10.1200/jco.2004.04.953 | PMID 15210736 Get It